Results 191 to 200 of about 204,284 (266)

Hydroxyurea (hydroxycarbamide) in haemoglobin SC disease: Moving from therapeutic hesitation to evidence‐guided care

British Journal of Haematology, Volume 209, Issue 3, Page 1428-1430, September 2026.
Girard et al. report a retrospective, single‐centre, real‐world study evaluating hydroxyurea (hydroxycarbamide) use in adults with haemoglobin SC disease in Quebec. Hydroxyurea was associated with reduced vaso‐occlusive crisis composite events, mostly mild adverse events and no observed hyperviscosity‐related complications, while highlighting adherence
Tahereh Setayesh
wiley   +1 more source

Educational Case: Glucose-6-phosphate dehydrogenase (G6PD) deficiency anemia. [PDF]

Acad Pathol
Bussing K, Brehl N, Inman A, Davidson D.
europepmc   +1 more source

The role of protein arginine methyltransferases in sickle cell‐mediated neurovascular impairments in mice

British Journal of Pharmacology, Volume 183, Issue 18, Page 5586-5601, September 2026.
Background and Purpose Sickle cell disease (SCD) is a hereditary blood disorder caused by mutation of β‐globin. In SCD, haemoglobin polymerization causes red blood cells to assume a rigid sickle‐shape leading to neurovascular alterations, including development of vascular dementia – characterized by cognitive impairment and reduced cerebral perfusion ...
Julia Zaccarelli‐Magalhães, Mariana Sayuri Berto Udo, Drew James Smith, Julia Langman, Luiz Henrique Matuguma, Guilherme Nagamine Gomes, Peter Rodriguez, Ammar Husan, Quanguang Zhang, Christopher G. Kevil, Cristiane Teresinha Citadin, Hung Wen Lin   +11 more
wiley   +1 more source

International flight-associated splenic infarction in a 33-year-old man with sickle cell trait. [PDF]

CMAJ
Chadelat A, Tassart M, Bachmeyer C.
europepmc   +1 more source

Severe maternal morbidity according to sickle cell disease genotype. [PDF]

Pregnancy (Hoboken)
Kawakita T, Furukawa N, Jones SA, Gangji SN.   +3 more
europepmc   +1 more source

Multidimensional Predictors of Disease Severity and Health Outcomes in Patients with Sickle Cell Disease: <i>A Data-Driven Clinical Insight</i>. [PDF]

Saudi Med J
Alzahrani HA, Almaghrabi ROM, Alharbi R, Alghamdi AS, Albanghali MA, Alyahyawi HE, Alruwetei AM, Garah B, Alzahrani M, Hjar SH, Shaker S.   +10 more
europepmc   +1 more source

Postoperative Complications in Patients With Sickle Cell Disease After Total Shoulder Arthroplasty. [PDF]

J Am Acad Orthop Surg Glob Res Rev
Zehner KM, Maloy GC, Slevin J, Day W, Ng M, Luo X, Grauer JN, Varthi AG.   +7 more
europepmc   +1 more source

Proximal tubulopathy in adult sickle cell disease: association of alpha-1 microglobulin. [PDF]

Clinics (Sao Paulo)
Engole YM, Nlandu YM, Nkodila AN, Makanzu B, Mvita Y, Ngoy GM, Mansoni BM, Mvibudulu R, Lukoki B, Nyemba SM, Kinja LZ, Sumaili EK.   +11 more
europepmc   +1 more source

Hidden burdens: The dual burden of subclinical iron deficiency and hemoglobinopathies in afro-descendant populations of Colombia's Pacific coast: A public health concern. [PDF]

J Public Health Res
Marquez B Y, Castillo B M, Mora B AI, Oliveros R AL, Castillo L LF, Marquez B B, Bernal JE, Briceño Balcazar I.   +7 more
europepmc   +1 more source

GBT-1118 Rescued Impaired Bone Formation but Failed to Rescue Material Properties in Humanized Sickle-Cell-Disease Murine Model. [PDF]

Cells
Clarke K, He W, Menon N, Schmidt T, Deymier A, Hurley M.   +5 more
europepmc   +1 more source